A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis
暂无分享,去创建一个
Peter Vestergaard | Bernard M J Uitdehaag | Frank de Vries | Hubert G M Leufkens | C. Cooper | B. Uitdehaag | P. Vestergaard | H. Leufkens | F. de Vries | T. V. van Staa | Cyrus Cooper | Joan Bentzen | M. Bazelier | Tjeerd-Pieter van Staa | Marloes T Bazelier | J. Bentzen | C. Cooper | C. Cooper
[1] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[2] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[3] J. Herbert,et al. Fracture history and bone loss in patients with MS , 1998, Neurology.
[4] C. Cooper,et al. Interpretation and use of FRAX in clinical practice , 2011, Osteoporosis International.
[5] J. Hentz,et al. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies , 2010, Osteoporosis International.
[6] G. Gronseth,et al. Invited Article: Practice parameters and technology assessments , 2008, Neurology.
[7] J. Herbert,et al. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.
[8] J. David,et al. The multiple faces of autoimmune-mediated bone loss , 2010, Nature Reviews Endocrinology.
[9] K. Nakken,et al. Bone loss associated with use of antiepileptic drugs , 2010, Expert opinion on drug safety.
[10] M. Ramanathan,et al. Risk of bone loss in men with multiple sclerosis , 2004, Multiple sclerosis.
[11] Chi C Cho,et al. Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. , 2006, Archives of physical medicine and rehabilitation.
[12] A. Parfitt,et al. Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] Chi C Cho,et al. Injurious falls among middle aged and older adults with multiple sclerosis. , 2008, Archives of physical medicine and rehabilitation.
[14] C. Chenu,et al. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. , 2006, Bone.
[15] S. Ozgoçmen,et al. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity , 2005, Journal of Bone and Mineral Metabolism.
[16] Jacques P. Brown,et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women , 2007, Osteoporosis International.
[17] P. Vestergaard,et al. Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers , 2012, Multiple sclerosis.
[18] A. Bertolotto,et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. , 2004, The Journal of clinical endocrinology and metabolism.
[19] G. Gronseth,et al. Invited Article: Lost in a jungle of evidence , 2008, Neurology.
[20] W A Ray,et al. Antidepressants and the risk of falls among nursing home residents. , 1998, The New England journal of medicine.
[21] Cecilia Lundholm,et al. Predicting accidental falls in people with multiple sclerosis — a longitudinal study , 2009, Clinical rehabilitation.
[22] O. Johnell,et al. FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.
[23] N. D. Nguyen,et al. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks , 2008, Osteoporosis International.
[24] C. Cooper,et al. The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Robert A Gross,et al. Levels of evidence , 2008, Neurology.
[26] L Abenhaim,et al. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.
[27] J. Herbert,et al. Reduced Bone Mass and Fat-Free Mass in Women with Multiple Sclerosis: Effects of Ambulatory Status and Glucocorticoid Use , 1997, Calcified Tissue International.
[28] A. Siva,et al. Bone status in multiple sclerosis: beyond corticosteroids , 2003, Multiple sclerosis.
[29] T. Walley,et al. The UK General Practice Research Database , 1997, The Lancet.